(Q33304691)

English

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer (English)

1 reference

Europe PubMed Central

25 July 2017

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Eui Kyu Chie

7

0 references

object named as

Se-Hoon Lee

6

0 references

13

object named as

Dong-Young Noh

1 reference

Europe PubMed Central

25 July 2017

16

object named as

Yung-Jue Bang

1 reference

Europe PubMed Central

25 July 2017

2

object named as

Seock-Ah Im

1 reference

Europe PubMed Central

25 July 2017

4

object named as

Do-Youn Oh

1 reference

Europe PubMed Central

25 July 2017

11

object named as

Tae-You Kim

1 reference

Europe PubMed Central

25 July 2017

8

object named as

Wonshik Han

1 reference

Europe PubMed Central

25 July 2017

10

object named as

Woo Kyung Moon

1 reference

Europe PubMed Central

25 July 2017

14

object named as

Dae Seog Heo

1 reference

Europe PubMed Central

25 July 2017

1

object named as

Bhumsuk Keam

1 reference

Europe PubMed Central

25 July 2017

author name string

Hee-Jun Kim

3

1 reference

Europe PubMed Central

25 July 2017

Jee Hyun Kim

5

1 reference

Europe PubMed Central

25 July 2017

Dong-Wan Kim

9

1 reference

Europe PubMed Central

25 July 2017

In Ae Park

12

1 reference

Europe PubMed Central

25 July 2017

Sung Whan Ha

15

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 November 2007

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

7

1 reference

Europe PubMed Central

25 July 2017

203

1 reference

Europe PubMed Central

25 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-7-203

0 references

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Prognostic markers in triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Primary systemic therapy in operable breast cancer: clinical data and biological fall-out

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Towards a novel classification of human malignancies based on gene expression patterns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2217558

21 June 2018

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-203

21 January 2018

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-203

21 January 2018

A phase II study of neoadjuvant docetaxel plus doxorubicin (KBCS-01) in stage II, III breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-203

21 January 2018

Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-203

21 January 2018

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-203

21 January 2018

The analysis of prognostic factors in stage III-B non-inflammatory breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17976237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-7-203

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33304691&oldid=1987479618"